Standardized tapering off subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy

Lars K Markvardsen*, Søren H Sindrup, Ingelise Christiansen, Aisha M Sheikh, Jakob V Holbech, Henning Andersen

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Abstract

BACKGROUND: Attempting discontinuation of treatment in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) is recommended. However, there is no evidence based regimen for tapering off subcutaneous immunoglobulin (SCIG). This trial investigated stepwise tapering off SCIG to detect remission and the lowest effective dosage. During tapering off, frequent vs less frequent clinical evaluation was compared.

METHODS: Patients with CIDP receiving a stable SCIG dosage followed a standardized tapering off regimen: 90%, 75%, 50%, 25% and 0% of the initial dose every 12th week, pending no deterioration occurred. In case of relapse during tapering off, the lowest effective dose was identified. Treatment with SCIG was registered for two years after participation. Disability score and grip strength were primary parameters. Participants were randomized to clinical evaluation every 6th week (frequent) or 12th week (less frequent).

RESULTS: Fifty-five patients were included of which thirty-five relapsed. Twenty patients (36%) were able to discontinue treatment without relapse. In relapsing patients, median dosage could be reduced by 10% (range, 0-75). After two years, 18 of 20 patients were still in remission without treatment. Frequent clinical evaluation did not detect deterioration more frequently than less frequent evaluation; RR 0.5 (95% CI, 0.2-1.2) (p = 0.17).

CONCLUSION: In stable CIDP patients, SCIG could be completely tapered off in 36% of the patients and only in 10% of these patients relapse occurred during the following two years. More frequent evaluation was not superior to detect deterioration.

OriginalsprogEngelsk
TidsskriftJournal of Neuromuscular Diseases
Vol/bind10
Nummer5
Sider (fra-til)787-796
Antal sider10
ISSN2214-3599
DOI
StatusUdgivet - sep. 2023

Fingeraftryk

Dyk ned i forskningsemnerne om 'Standardized tapering off subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy'. Sammen danner de et unikt fingeraftryk.

Citationsformater